BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

80 related articles for article (PubMed ID: 6301193)

  • 1. Pathological and immunological identification of target cells for murine leukemia viruses in rats.
    Takeichi N; Suzuki K; Kasai M; Moriuchi T; Kobayashi H
    Nihon Ketsueki Gakkai Zasshi; 1982 Dec; 45(7):1277-86. PubMed ID: 6301193
    [No Abstract]   [Full Text] [Related]  

  • 2. A new model for leukemia-lymphoma metastasis: differential growth and rejection of murine lymphoid-leukemia cell lines in the bone marrow.
    Kamenov B; Kieran MW; Leigh JB; Greenberg AH; Longenecker BM
    Symp Fundam Cancer Res; 1983; 36():245-64. PubMed ID: 6679093
    [No Abstract]   [Full Text] [Related]  

  • 3. A thymus cell marker in murine leukemia virus-induced lymphomas of rats.
    Takeichi N; Suzuki K; Kobayashi H
    Cancer Res; 1979 Sep; 39(9):3749-51. PubMed ID: 225024
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Production of migration inhibition factor by spleen cells of normal rats upon culture in vitro with tumor cells and cells expressing endogenous virus.
    Sharma JM; Herberman RB; Djeu JY; Nunn ME
    J Immunol; 1979 Jul; 123(1):222-31. PubMed ID: 221590
    [No Abstract]   [Full Text] [Related]  

  • 5. Antibody response and leukemia development in mice inoculated neonatally with the Moloney virus.
    Klein E; Klein G
    Cancer Res; 1965 Jul; 25(6):851-4. PubMed ID: 4284254
    [No Abstract]   [Full Text] [Related]  

  • 6. Immunopathogenicity and oncogenicity of murine leukemia viruses. II. Infection of mice and rats with Scripps leukemia virus.
    Del Villano BC; Croker BP; McConahey PJ; Dixon FJ
    Am J Pathol; 1976 Feb; 82(2):299-314. PubMed ID: 175661
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Immunological activation of oncogenic viruses: interrelationship of immunostimulation and immunosuppression.
    Hirsch MS
    Johns Hopkins Med J Suppl; 1974; 3():177-85. PubMed ID: 4153909
    [No Abstract]   [Full Text] [Related]  

  • 8. Antigenic modulation as a mechanism for tumor escape from immune destruction: identification of modulation-positive and modulation-negative mouse lymphomas with xenoantisera to murine leukemia virus gp70.
    Stackpole CW; Cremona P; Leonard C; Stremmel P
    J Immunol; 1980 Oct; 125(4):1715-23. PubMed ID: 6251136
    [No Abstract]   [Full Text] [Related]  

  • 9. Experimental models and conceptual approaches to studies of lymphomas and leukemia: etiology, biology, and control.
    Ihle JN
    Semin Hematol; 1978 Apr; 15(2):95-115. PubMed ID: 206975
    [No Abstract]   [Full Text] [Related]  

  • 10. Serological analysis of cell surface antigens of tumors induced by murine leukemia virus.
    Herberman RB
    J Natl Cancer Inst; 1972 Jan; 48(1):265-71. PubMed ID: 4119883
    [No Abstract]   [Full Text] [Related]  

  • 11. Isolation and characterization of a lymphatic leukemia virus in the Friend virus complex.
    Steeves RA; Eckner RJ; Bennett M; Mirand EA; Trudel PJ
    J Natl Cancer Inst; 1971 Jun; 46(6):1209-17. PubMed ID: 4325930
    [No Abstract]   [Full Text] [Related]  

  • 12. Susceptibility of Japanese mouse strains to murine leukemia viruses.
    Hoshino H; Yamamoto T
    Jpn J Exp Med; 1979 Aug; 49(4):293-4. PubMed ID: 228099
    [No Abstract]   [Full Text] [Related]  

  • 13. Malignant lymphomas of extrathymic origin induced in rats by murine erythroblastosis virus.
    Kirsten WH; Mayer LA
    J Natl Cancer Inst; 1969 Sep; 43(3):735-46. PubMed ID: 4309615
    [No Abstract]   [Full Text] [Related]  

  • 14. [On the effectivity in vitro of heterologous rabbit antisera against mouse leukemia cells (author's transl)].
    Milleck J
    Arch Geschwulstforsch; 1973; 42(4):274-84. PubMed ID: 4138846
    [No Abstract]   [Full Text] [Related]  

  • 15. Immunological analysis of N-nitrosourea-induced rat leukemia and experimental trials for therapy of human leukemia.
    Imamura N; Okada K
    Nihon Ketsueki Gakkai Zasshi; 1982 Dec; 45(7):1307-13. PubMed ID: 7168310
    [No Abstract]   [Full Text] [Related]  

  • 16. Effects of antilymphocyte serum on the induction of neoplasms of lymphoreticular tissues.
    Law LW
    Fed Proc; 1970; 29(1):171-4. PubMed ID: 4312738
    [No Abstract]   [Full Text] [Related]  

  • 17. Liposomes as a tool to study the role of membrane presentation in the immunogenicity of a MuLV-related tumor antigen.
    Gerlier D; Bakouche O; Dore JF
    J Immunol; 1983 Jul; 131(1):485-90. PubMed ID: 6190925
    [No Abstract]   [Full Text] [Related]  

  • 18. Immune responses to virus induced experimental leukemia and to human leukemia.
    Herberman RB
    Johns Hopkins Med J Suppl; 1974; 3():3-14. PubMed ID: 4371287
    [No Abstract]   [Full Text] [Related]  

  • 19. Protection against radiation leukemogenesis by repeated injections of immune and nonimmune foreign sera.
    Ferrer JF; Lieberman M; Kaplan HS
    Cancer Res; 1973 Jun; 33(6):1339-43. PubMed ID: 4352370
    [No Abstract]   [Full Text] [Related]  

  • 20. Pathogenesis of Abelson-virus-induced murine leukemia.
    Siegler R; Zajdel S
    J Natl Cancer Inst; 1972 Jan; 48(1):189-218. PubMed ID: 4347027
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.